Eczema: FDA reporting patterns
49,638 FDA FAERS reports mention Eczema. 16,896 reports have a serious outcome flag.
Medicines named as suspect
- Dupilumab: 26,495 reports
- Adalimumab: 1,619 reports
- Infliximab: 1,071 reports
- Denosumab: 660 reports
- Omalizumab: 648 reports
- Prednisone: 623 reports
- Secukinumab: 579 reports
- Budesonide: 576 reports
- Adapalene: 568 reports
- Etanercept: 557 reports
- Fluticasone: 514 reports
- Levothyroxine: 490 reports
FAERS reports describe events reported after a medicine was taken. They do not prove that the medicine caused an event, measure how often a side effect occurs, or estimate personal risk.
Source: FDA FAERS via openFDA. FAERS data through 2026-06-30. Sources, methods, and limitations.